# Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2

**Authors:** Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Takeshi Inoue, Shunsuke Usami, Po-Min Chen, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Kosuke Doi, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Tomohiro Dohke, Toru Sato, Ryusuke Nishikawa, Takeshi Kimura, Kaoru Dohi

PMC · DOI: 10.1016/j.rpth.2025.102965 · Research and Practice in Thrombosis and Haemostasis · 2025-07-03

## TL;DR

This study identifies different risk factors for all-cause and pulmonary embolism (PE)-related death in patients with acute PE, which can help guide treatment decisions.

## Contribution

The study reveals distinct risk factors for PE-related death compared to all-cause death in acute PE patients.

## Key findings

- The 30-day incidence of all-cause and PE-related death was 6.4% and 3.4%, respectively.
- Risk factors for PE-related death included hypoxemia, tachycardia, and right ventricular dysfunction.
- Active cancer and male sex were risk factors for all-cause death but not PE-related death.

## Abstract

Accurate risk prediction of early mortality, particularly pulmonary embolism (PE)-related death, in patients with acute PE has become more important for selecting optimal management strategies.

To evaluate the cumulative 30-day incidence of and risk factors for all-cause and PE-related death within 30 days.

In the COMMAND VTE Registry-2, which enrolled symptomatic patients with venous thromboembolism at 31 centers in Japan, we analyzed 2035 patients with acute PE.

The cumulative 30-day incidence of all-cause and PE-related death was 6.4% and 3.4%, respectively. Independent risk factors for all-cause and PE-related death were age >80 years (hazard ratio [HR], 2.43; 95% CI, 1.45-4.08; P < .001), hypoxemia (HR, 3.36; 95% CI, 1.07-10.5; P = .04), tachycardia (HR, 3.78; 95% CI, 2.20-6.50; P < .001), hypotension (HR, 5.43; 95% CI, 3.17-9.29; P < .001), an abnormal leukocyte count (HR, 1.78; 95% CI, 1.08-2.93; P = .02), and the absence of proximal deep vein thrombosis (HR, 2.58; 95% CI, 1.51-4.39; P < .001). Active cancer (HR, 2.59; 95% CI, 1.75-3.82; P < .001) and male sex (HR, 1.56; 95% CI, 1.07-2.28; P = .02) were independent risk factors for all-cause death, but not PE-related death. Chronic heart or lung disease (HR, 1.72; 95% CI, 1.02-2.90; P = .04) and right ventricular dysfunction (HR, 2.61; 95% CI, 1.02-6.70; P = .046) were independent risk factors for PE-related death, but not all-cause death.

We identified several independent risk factors for PE-related death within 30 days, which differed from those of all-cause death. Risk factors specifically for PE-related death may be useful in decision-making for optimal treatment strategies for acute PE.

•Early mortality prediction, notably PE-related, is key for optimal PE care.•We evaluated 30-day cumulative incidence and risk factors for all-cause and PE-related death.•The cumulative incidence was 6.4% for all-cause death and 3.4% for PE-related death.•Independent risk factors for PE-related death were distinct from those of all-cause death.

Early mortality prediction, notably PE-related, is key for optimal PE care.

We evaluated 30-day cumulative incidence and risk factors for all-cause and PE-related death.

The cumulative incidence was 6.4% for all-cause death and 3.4% for PE-related death.

Independent risk factors for PE-related death were distinct from those of all-cause death.

## Linked entities

- **Diseases:** pulmonary embolism (MONDO:0005279), venous thromboembolism (MONDO:0005399), cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** right ventricular dysfunction (MESH:D018497), venous thromboembolism (MESH:D054556), hypoxemia (MESH:D000860), deep vein thrombosis (MESH:D020246), Chronic heart or lung disease (MESH:D008171), cancer (MESH:D009369), hypotension (MESH:D007022), tachycardia (MESH:D013610), PE (MESH:D011655), death (MESH:D003643)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12336812/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12336812/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12336812/full.md

---
Source: https://tomesphere.com/paper/PMC12336812